SCHEMBL4906332

SCHEMBL4906332

C=C(C)C(=O)OCN1CCCC1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.45
PIK3CD O00329 1/20 0.42
KMT2A Q03164 3/20 0.41
HTT P42858 1/20 0.37
ATM Q13315 1/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.36
CHRM2 P08172 2/20 0.36
CHRM5 P08912 2/20 0.36
CYP2D6 P10635 2/20 0.36
CHRM1 P11229 2/20 0.36
CHRM3 P20309 2/20 0.36
ALOX12 P18054 1/20 0.36
NFKB1 P19838 1/20 0.36
APEX1 P27695 1/20 0.36
MAPK1 P28482 1/20 0.36
PMP22 Q01453 1/20 0.36
CYP1A2 P05177 1/20 0.36
CHRM4 P08173 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12656022 0.94 KMT2A (0.42) TSHRPIK3CDKMT2AATMALDH1A1
SCHEMBL16389265 0.85 PIK3CD (0.43) TSHRPIK3CDKMT2AALDH1A1LMNA
SCHEMBL163326 0.84 KMT2A (0.46) TSHRPIK3CDKMT2AALDH1A1
SCHEMBL8069623 0.83 TSHR (0.50) TSHRPIK3CDKMT2AHTTALDH1A1
SCHEMBL29144401 0.83 KMT2A (0.53) TSHRPIK3CDKMT2AHTTALDH1A1
SCHEMBL161624 0.82 TSHR (0.44) TSHRKMT2AHTTALDH1A1APEX1
SCHEMBL1093758 0.82 KMT2A (0.41) TSHRPIK3CDKMT2AALDH1A1
SCHEMBL7978944 0.81 KMT2A (0.40) TSHRPIK3CDKMT2AHTTALDH1A1
SCHEMBL31404679 0.81 TSHR (0.46) TSHRKMT2AHTTALDH1A1APEX1
SCHEMBL11890775 0.80 KMT2A (0.42) TSHRPIK3CDKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025045458-A1 OPHTHALMIC DEVICES HAVING A HIGH REFRACTIVE INDEX BAUSCH + LOMB IRELAND LIMITED (IE) 2025-03-06 WO claimed
US-20250073018-A1 OPHTHALMIC DEVICES HAVING A HIGH REFRACTIVE INDEX JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT 2025-03-06 US claimed
US-9512325-B2 Compositions comprising a reactive monomer and uses thereof ISP INVESTMENTS LLC (US) 2016-12-06 US claimed
US-20250145562-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC DEVICES JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT 2025-05-08 US disclosed
WO-2025045458-A1 OPHTHALMIC DEVICES HAVING A HIGH REFRACTIVE INDEX BAUSCH + LOMB IRELAND LIMITED (IE) 2025-03-06 WO disclosed
US-20250073018-A1 OPHTHALMIC DEVICES HAVING A HIGH REFRACTIVE INDEX JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT 2025-03-06 US disclosed
US-9512325-B2 Compositions comprising a reactive monomer and uses thereof ISP INVESTMENTS LLC (US) 2016-12-06 US disclosed
US-9512325-B2 Compositions comprising a reactive monomer and uses thereof ISP INVESTMENTS LLC (US) 2016-12-06 US disclosed
US-8778575-B2 Curable composition, color filter using the same and manufacturing method therefor, and solid image pickup element FUJIFILM CORPORATION (JP) 2014-07-15 US disclosed
US-20130150481-A1 COMPOSITIONS COMPRISING A REACTIVE MONOMER AND USES THEREOF HERCULES LLC 2013-06-13 US disclosed
US-20130150481-A1 COMPOSITIONS COMPRISING A REACTIVE MONOMER AND USES THEREOF HERCULES LLC 2013-06-13 US disclosed
US-6465588-B1 PARTICULARLY SUITABLE FOR FOLDABLE INTRAOCULAR LENS SANTEN PHARMACEUTICAL CO., LTD. (JP) 2002-10-15 US disclosed
EP-0869138-B1 NOVEL COPOLYMERS FORMED FROM THREE COMPONENTS AND INTRAOCULAR LENSES MADE THEREOF SANTEN PHARMACEUTICAL CO LTD (JP) 2002-08-07 EP disclosed
US-6132462-A HYDROXYALKYL (ALKYL)ACRYLATE; PYRROLIDONE-CONTAINING ACRYLIC ESTER, AMIDE, OR IMIDE; AND A LOWER ALKYL (ALKYL)ACRYLATE TERPOLYMER; FOLDABLE LENSE HAVING GIVEN REFRACTIVE INDEX, RECOVERY SPEED FROM FOLD STATE AND TENSILE STRENGTH SANTEN PHARMACEUTICAL CO., LTD. (JP) 2000-10-17 US disclosed
EP-1026182-A1 FOUR COMPONENT COPOLYMER AND THE OCULAR LENS MADE THEREOF SANTEN PHARMACEUTICAL CO., LTD (JP) 2000-08-09 EP disclosed
US-5947274-A Desiccating container for moisture-sensitive material SMITHKLINE BEECHAM P.L.C. (GB) 1999-09-07 US disclosed
EP-0869138-A1 NOVEL COPOLYMERS FORMED FROM THREE COMPONENTS AND INTRAOCULAR LENSES MADE THEREOF SANTEN PHARMACEUTICAL CO., LTD. (JP) 1998-10-07 EP disclosed
US-5294401-A Blood gas exchange TERUMO KABUSHIKI KAISHA (JP) 1994-03-15 US disclosed
EP-0354959-B1 MEMBRANE TYPE ARTIFICIAL LUNG AND PRODUCTION THEREOF TERUMO KABUSHIKI KAISHA (JP) 1993-01-20 EP disclosed
EP-0354959-A1 MEMBRANE TYPE ARTIFICIAL LUNG AND PRODUCTION THEREOF TERUMO KABUSHIKI KAISHA (JP) 1990-02-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250145562-A1 VISIBLE LIGHT ABSORBERS FOR OPHTHALMIC DEVICES CRY1, NFXL1, ZYX TSHR 3668/4885PIK3CD 4542/4885KMT2A 2325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.